Healthcare
FDA requires new safety warnings for GLP‑1 weight‑loss drugs over possible vision‑loss risk
The U.S. Food and Drug Administration has instructed manufacturers of GLP‑1 weight‑loss medications to update their labeling to include a warning about a potential increased risk of a rare eye condition that could lead…
3 sources1 claims checked6d ago
1 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis